RNAi for Therapeutic Market Size Report 2023-2030 106 Pages Report - Benzinga
BNTC Stock | USD 10.09 0.36 3.70% |
About 54% of Benitec Biopharma's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Benitec Biopharma Ltd suggests that some traders are interested. The current market sentiment, together with Benitec Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Benitec Biopharma stock news signals to limit their universe of possible portfolio assets.
Benitec |
RNAi for Therapeutic Market Size Report 2023-2030 106 Pages Report Benzinga
Read at news.google.com
Benitec Biopharma Fundamental Analysis
We analyze Benitec Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Benitec Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Benitec Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Benitec Biopharma is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Benitec Biopharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Benitec Biopharma stock to make a market-neutral strategy. Peer analysis of Benitec Biopharma could also be used in its relative valuation, which is a method of valuing Benitec Biopharma by comparing valuation metrics with similar companies.
Peers
Benitec Biopharma Related Equities
ALRN | Aileron Therapeutics | 4.38 | ||||
ZURA | Zura Bio | 1.67 | ||||
CAPR | Capricor Therapeutics | 0.16 | ||||
NXTC | NextCure | 2.50 | ||||
ZVSA | ZyVersa Therapeutics | 3.60 | ||||
BPTH | Bio Path | 3.75 |
Complementary Tools for Benitec Stock analysis
When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |